Sweet Success Begins to Ramp-Up Shipments for Flagship GlucaSafe Beverage

Delivery Scheduled to be Completed This Week to Initially 90 Plus Pharmacy Departments in 15 Northern States Through Key Distributor Network


SAN ANTONIO, Oct. 8, 2007 (PRIME NEWSWIRE) -- Sweet Success Enterprises, Inc. (OTCBB:SWTS), the maker of a line of innovative and delicious healthy-lifestyle beverages, announced today that the company's revolutionary GlucaSafe(tm), a functional health beverage developed to maintain healthy glucose levels, lower hypertension and cholesterol, has continued to ramp up its great tasting, all-natural, glucose control beverage for delivery this week to initially 90 plus pharmacy departments in 15 northern states with some sales already reported at retail.

The clinical studies on GlucaSafe(tm) ingredients have added a strong niche for the GlucaSafe(tm) product which appears popular among pharmacists looking for a great tasting glucose control beverage and GlucaSafe(tm) has only 2 grams of sugar, no carbs and is all-natural.

"We know we have a superior tasting beverage with its green tea, white tea and pomegranate extract all of which also serve as an antioxidant promoting overall health and immunity," said William Gallagher, Sweet Success CEO. "Other ingredients in GlucaSafe(tm) have undergone substantial clinical trials for their ingredients, including cinnamon extract, by the USDA, which has shown to help stabilize glucose levels, banaba leaf, a glucose stabilizer that controls appetite, food cravings and accordingly promotes weight loss, chromium polynicotinate, which promotes the regulation and maintenance of normal cholesterol levels and supports the metabolism of fats and sugars, and stevioside, which has been shown to reduce high blood sugar, lower blood pressure and is considered an alternative supplementary therapy for hypertension."

Added Gallagher, "Indications are beginning to show we may have a blockbuster neutraceutical beverage on our hands."

The Sweet Success Enterprises, Inc. logo is available at http://www.primenewswire.com/newsroom/prs/?pkgid=3428

Product statements have not been evaluated by the FDA. The products are not intended to diagnose, treat, cure or prevent disease.

"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995: This release includes forward-looking statements intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. All statements which address actual results could differ materially from those expressed or implied in forward-looking statements. These statements are made on the basis of management's views and assumptions. As a result, there can be no assurance that management's expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as management "believes," "expects," "anticipates," "foresees," "forecasts," "estimates" or other words or phrases of similar import. Similarly, statements in this release that describe the Company's business strategy, outlook, objectives, plans, intentions or goals also are forward-looking statements. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. Management cautions that the ability to attract clients and generate business may be affected by a decline in the Company's financial ratings, the competitive environment, the Company's ability to raise sufficient capital to meet the collateral requirements associated with its current business and to fund the Company's continuing operations and changes in market conditions.


            

Contact Data